Opportunity Information: Apply for 72068521APS00001
The USAID/Senegal opportunity titled "Improving Health Status and Human Capital in Senegal" (Funding Opportunity Number 72068521APS00001) is an Annual Program Statement designed to finance one or multiple cooperative agreements that advance USAID-Dakar's Health, Population, and Nutrition (HPN) portfolio goals over FY 2021 through FY 2026. In plain terms, the grant is structured to support a set of related health and human-capital investments over several years, with the expectation that funded partners will implement activities aligned to USAID's strategic results for Senegal, rather than a single narrow project.
The funding is organized under an "umbrella" APS that lays out the overall program context, guiding principles, how applications will be evaluated, and what submission materials are required. Under that umbrella sit three distinct component programs (with additional annexes) that spell out the component-specific objectives, expected results, and requirements, including funding ceilings. This structure signals that applicants may propose work under one or more components, and that USAID is looking for partners who can contribute to a coordinated portfolio, not just isolated interventions.
Component 1 focuses on central-level health systems strengthening, targeting national systems and functions managed at the Ministry of Health level. While the notice does not list every activity, the intent is to improve the performance of core system building blocks that influence the entire country, such as governance and stewardship, policy and planning, national supply and logistics approaches, health information and data use, quality standards, financing-related functions, and other cross-cutting mechanisms that enable consistent service delivery nationwide. The logic behind this component is that strengthening national systems improves scale, sustainability, and alignment across regions and districts.
Component 2 is centered on integrated district health and is explicitly geographic, providing comprehensive support to health districts in five priority regions: Diourbel, Kolda, Sedhiou, Tambacounda, and Kedougou. The emphasis on "integrated" suggests USAID is prioritizing coordinated service delivery and management at the district level, where planning, supervision, community engagement, and routine service delivery come together. This component is meant to translate national policies into practical improvements in frontline services and district performance, typically involving capacity building, supportive supervision, data-driven management, and strengthening connections between facilities, communities, and referral systems.
Component 3 targets urban health and is tailored to the realities of marginalized and underserved districts in the Dakar Region. It focuses on improving outcomes across a set of high-priority technical areas: reproductive, maternal, newborn, child, and adolescent health (RMNCAH); family planning (FP); malaria (M); nutrition (N); and water, sanitation, and hygiene (WASH). The explicit urban framing matters because barriers in dense urban settings often differ from rural contexts, with challenges like inequities within cities, mobility, informal settlements, service congestion, and gaps in WASH conditions that affect health. This component indicates USAID is looking for approaches designed specifically for urban systems and populations, rather than simply adapting rural programming.
From an administrative standpoint, the opportunity is a discretionary award using a cooperative agreement mechanism, meaning USAID anticipates substantial involvement during implementation (for example, in collaboration on technical direction, monitoring, or coordination). Eligibility is listed as unrestricted, opening the competition broadly to qualified organizations. The award ceiling is $88,000,000, reflecting a potentially large multi-award portfolio rather than a single small project, and the originating office is USAID-Dakar. The original closing date listed is October 25, 2021, and the opportunity falls under the health funding activity category (CFDA/Assistance Listing 98.001).
Overall, the APS is essentially a multi-year, multi-component funding framework meant to improve health status and strengthen human capital in Senegal by combining national-level system reforms, intensive district support in selected regions, and urban-focused interventions in Dakar that address RMNCAH, family planning, malaria, nutrition, and WASH in underserved communities.Apply for 72068521APS00001
- The Senegal USAID-Dakar in the health sector is offering a public funding opportunity titled "Improving Health Status and Human Capital in Senegal" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
- This funding opportunity was created on 2020-10-26.
- Applicants must submit their applications by 2021-10-25. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $88,000,000.00 in funding.
- Eligible applicants include: Unrestricted.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: USAID/Senegal - Improving Health Status and Human Capital in Senegal (72068521APS00001)
1) What is the title of this USAID/Senegal funding opportunity?
The opportunity is titled "Improving Health Status and Human Capital in Senegal."
2) What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is 72068521APS00001.
3) What type of funding announcement is this?
This is an Annual Program Statement (APS). It is structured as an umbrella funding framework that sets overall context, principles, evaluation approach, and required submission materials, with component programs beneath it that include component-specific objectives and requirements.
4) What does it mean that this APS is an "umbrella" APS?
It means the APS provides the overarching program goals and application rules, while the detailed programming is organized into separate component programs (with annexes) that specify objectives, expected results, and requirements (including funding ceilings) for each component.
5) What is USAID trying to achieve through this opportunity?
The APS is intended to advance USAID-Dakar's Health, Population, and Nutrition (HPN) portfolio goals over FY 2021 through FY 2026 by improving health status and strengthening human capital in Senegal through coordinated investments.
6) Over what time period is this APS intended to support activities?
The APS is designed to support a portfolio of activities across FY 2021 through FY 2026.
7) Is this meant to fund one project or multiple activities?
It is designed to finance one or multiple cooperative agreements that together advance USAID-Dakar's HPN goals. The structure signals a coordinated portfolio approach rather than a single narrow project.
8) What award mechanism will USAID use?
The opportunity uses a cooperative agreement mechanism.
9) What does a cooperative agreement imply for implementation?
A cooperative agreement implies USAID anticipates substantial involvement during implementation, such as collaboration on technical direction, monitoring, or coordination.
10) Is this a discretionary award?
Yes. The opportunity is described as a discretionary award.
11) Who is the originating office for this opportunity?
The originating office is USAID-Dakar.
12) What is the total award ceiling listed for this opportunity?
The award ceiling is $88,000,000.
13) Does the award ceiling mean one applicant can receive the full $88,000,000?
The information provided describes a potentially large, multi-award portfolio under the APS (not necessarily a single award). The $88,000,000 ceiling reflects the overall scale of the opportunity as presented.
14) What is the Assistance Listing (CFDA) number for this opportunity?
The CFDA/Assistance Listing number is 98.001.
15) What is the funding activity category?
The opportunity falls under the health funding activity category.
16) Who is eligible to apply?
Eligibility is listed as unrestricted, meaning the competition is open broadly to qualified organizations.
17) What is the closing date listed for the opportunity?
The original closing date listed is October 25, 2021.
18) How is the program organized?
The APS includes three distinct component programs (with additional annexes). Each component includes its own objectives, expected results, and requirements, including funding ceilings.
19) Can an applicant propose work under more than one component?
Yes. The structure signals that applicants may propose work under one or more components.
20) What does USAID appear to be looking for in applicants?
Based on the APS structure, USAID appears to be looking for partners that can contribute to a coordinated health and human-capital portfolio aligned with USAID strategic results for Senegal, rather than isolated interventions.
21) What is Component 1 focused on?
Component 1 focuses on central-level health systems strengthening, targeting national systems and functions managed at the Ministry of Health level.
22) What kinds of areas does Component 1 generally cover?
Component 1 is described as aiming to improve core health system building blocks that affect nationwide performance. Examples mentioned include governance and stewardship, policy and planning, national supply and logistics approaches, health information and data use, quality standards, financing-related functions, and other cross-cutting mechanisms that support consistent service delivery across the country.
23) What is the rationale for investing in central-level systems under Component 1?
The logic stated is that strengthening national systems improves scale, sustainability, and alignment across regions and districts.
24) What is Component 2 focused on?
Component 2 is centered on integrated district health and provides comprehensive support to health districts in specific priority regions.
25) Which regions are prioritized under Component 2?
Component 2 targets five priority regions: Diourbel, Kolda, Sedhiou, Tambacounda, and Kedougou.
26) What does "integrated district health" suggest in this APS?
It suggests an emphasis on coordinated service delivery and management at the district level, where planning, supervision, community engagement, and routine services connect.
27) What types of district-level improvements are implied under Component 2?
The description points to strengthening practical frontline performance through approaches such as capacity building, supportive supervision, data-driven management, and improved connections between facilities, communities, and referral systems.
28) What is Component 3 focused on?
Component 3 targets urban health, tailored to marginalized and underserved districts in the Dakar Region.
29) Which technical areas are explicitly highlighted under Component 3?
Component 3 focuses on improving outcomes in reproductive, maternal, newborn, child, and adolescent health (RMNCAH); family planning (FP); malaria (M); nutrition (N); and water, sanitation, and hygiene (WASH).
30) Why does the APS treat urban health as its own component?
The description indicates that barriers in dense urban settings can differ from rural contexts, including inequities within cities, mobility, informal settlements, service congestion, and WASH gaps that affect health. Component 3 indicates interest in approaches designed specifically for urban systems and populations.
31) Is Component 3 just rural programming moved into a city context?
No. The APS framing suggests USAID is looking for approaches designed specifically for urban contexts, not simply adapting rural programming.
32) What is the overall approach of the APS across all components?
Overall, the APS combines national-level system strengthening (Component 1), intensive district support in selected regions (Component 2), and targeted urban interventions in Dakar addressing RMNCAH, family planning, malaria, nutrition, and WASH (Component 3).
33) What kinds of application materials and evaluation criteria apply?
The APS umbrella is described as laying out guiding principles, how applications will be evaluated, and what submission materials are required. Component annexes then add component-specific objectives and requirements.
34) Is this opportunity designed for narrow, single-topic projects?
The description suggests the opposite: it is meant to support a set of related health and human-capital investments over several years, aligned with USAID strategic results for Senegal.
35) How does this APS link health outcomes and human capital?
Based on the description, the APS frames improvements in health status and health system performance as key drivers of stronger human capital, implemented through multi-level investments (national systems, district service delivery, and urban-focused interventions).
Browse more opportunities from the same category: Health
Next opportunity: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)
Previous opportunity: Assistive Technology Program
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for 72068521APS00001
Applicants also applied for:
Applicants who have applied for this opportunity (72068521APS00001) also looked into and applied for these:
| Funding Opportunity |
|---|
| NINDS Research Education Programs for Residents and Fellows in Neurological Disorders and Stroke (R25 - Clinical Trial Not Allowed) Apply for PAR 20 311 Funding Number: PAR 20 311 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) Apply for PAR 21 040 Funding Number: PAR 21 040 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Treatments for Lewy Body Dementias--Exploratory Clinical Trial (U01 Clinical Trial Required) Apply for RFA NS 21 008 Funding Number: RFA NS 21 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Regional Technology Transfer Accelerator Hubs for IDeA States (STTR) (UT2 - Clinical Trial Not Allowed) Apply for RFA GM 21 001 Funding Number: RFA GM 21 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Multi-Level HIV Prevention Interventions for Individuals at the Highest Risk of HIV Infection (R01 Clinical Trial Optional) Apply for RFA MD 21 001 Funding Number: RFA MD 21 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) Apply for RFA RM 21 007 Funding Number: RFA RM 21 007 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Promoting Viral Suppression among Individuals from Health Disparity Populations Engaged in HIV Care (R01 Clinical Trial Required) Apply for RFA MD 21 002 Funding Number: RFA MD 21 002 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Exploring the Scientific Value of Existing or New Sepsis Human Biospecimen Collections (R21/R33 - Clinical Trial Not Allowed) Apply for PAR 21 077 Funding Number: PAR 21 077 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) Apply for PAR 21 036 Funding Number: PAR 21 036 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required) Apply for PAR 21 045 Funding Number: PAR 21 045 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R43/R44 Clinical Trial Optional) Apply for RFA MH 21 112 Funding Number: RFA MH 21 112 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAAA Resource-Related Research Projects (R24 Clinical Trial Not Allowed) Apply for PAR 21 072 Funding Number: PAR 21 072 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) Apply for PAR 21 053 Funding Number: PAR 21 053 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R34 Clinical Trial Optional) Apply for RFA MH 21 111 Funding Number: RFA MH 21 111 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R01 Clinical Trial Optional) Apply for RFA MH 21 110 Funding Number: RFA MH 21 110 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Social Drivers of Mental Illnesses in Low- and Middle-Income Countries: Mechanisms and Pathways of Interventions for Youth (R01 Clinical Trial Optional) Apply for RFA MH 21 160 Funding Number: RFA MH 21 160 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NEI Collaborative Clinical Vision Project: Resource Center Grant (UG1- Clinical Trial Required) Apply for PAR 21 043 Funding Number: PAR 21 043 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) Apply for RFA MH 21 105 Funding Number: RFA MH 21 105 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Collaborative Clinical Vision Research : Chair's Grant (UG1-Clinical Trial Required) Apply for PAR 21 041 Funding Number: PAR 21 041 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional) Apply for PAR 21 079 Funding Number: PAR 21 079 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "72068521APS00001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
